Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Chinese Patent Office
US Department of Justice
McKesson
Colorcon
Federal Trade Commission
Dow
Harvard Business School
UBS
Medtronic

Generated: November 14, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 202586

« Back to Dashboard

NDA 202586 describes INDIUM IN 111 OXYQUINOLINE, which is a drug marketed by Bwxt Itg and Ge Healthcare and is included in two NDAs. It is available from one supplier. Additional details are available on the INDIUM IN 111 OXYQUINOLINE profile page.

The generic ingredient in INDIUM IN 111 OXYQUINOLINE is indium in-111 oxyquinoline. There are twenty-three drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the indium in-111 oxyquinoline profile page.
Summary for 202586
Tradename:INDIUM IN 111 OXYQUINOLINE
Applicant:Bwxt Itg
Ingredient:indium in-111 oxyquinoline
Patents:0
Formulation / Manufacturing:see details

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:INJECTABLE;INJECTIONStrength1mCi/ML
Approval Date:Jul 25, 2018TE:RLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cipla
Harvard Business School
Farmers Insurance
UBS
QuintilesIMS
Julphar
Express Scripts
AstraZeneca
US Department of Justice

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.